| Matthew Thomas Blair, CRNA | |
|
1900 Columbus Ave, Bay City, MI 48708-6880 | |
| (989) 894-3000 | |
| (989) 894-6138 |
| Full Name | Matthew Thomas Blair |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 10 Years |
| Location | 1900 Columbus Ave, Bay City, Michigan |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124431457 | NPI | - | NPPES |
| 101868 | Other | MI | AANA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | ARNP 9306516 (Florida) | Primary |
| 367500000X | Nurse Anesthetist, Certified Registered | 4704277505 (Michigan) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Ascension St Mary's Hospital | Saginaw, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Resource Anesthesiology Associates Of Mi Pc | 4082883053 | 68 |
News Archive
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität aim to find answers to in a new research project in which they will be researching micrometastases that can form new tumours years after skin cancer, for example, has been treated successfully.
Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.
National Cheng Kung University, southern Taiwan, has collaborated with Quanta Computer to launch a cloud solution expecting to provide neonatal intensive care unit doctors and parents access to a live video stream that they can watch anywhere from mobile devices such as smartphones and tablets.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
An examination of the heritability of atrial fibrillation (AF) among more than 4,000 participants in the Framingham Heart Study finds the occurrence of AF in first-degree relatives was associated with AF risk after adjustment for established AF risk factors and AF-related genetic variants, according to a study that will appear in the November 24 issue of JAMA.
› Verified 6 days ago
| Entity Name | Ascension St. Mary's Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1457306185 PECOS PAC ID: 6305737156 Enrollment ID: O20040322001854 |
News Archive
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität aim to find answers to in a new research project in which they will be researching micrometastases that can form new tumours years after skin cancer, for example, has been treated successfully.
Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.
National Cheng Kung University, southern Taiwan, has collaborated with Quanta Computer to launch a cloud solution expecting to provide neonatal intensive care unit doctors and parents access to a live video stream that they can watch anywhere from mobile devices such as smartphones and tablets.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
An examination of the heritability of atrial fibrillation (AF) among more than 4,000 participants in the Framingham Heart Study finds the occurrence of AF in first-degree relatives was associated with AF risk after adjustment for established AF risk factors and AF-related genetic variants, according to a study that will appear in the November 24 issue of JAMA.
› Verified 6 days ago
| Entity Name | Resource Anesthesiology Associates Of Mi Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568755882 PECOS PAC ID: 4082883053 Enrollment ID: O20110808000715 |
News Archive
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität aim to find answers to in a new research project in which they will be researching micrometastases that can form new tumours years after skin cancer, for example, has been treated successfully.
Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.
National Cheng Kung University, southern Taiwan, has collaborated with Quanta Computer to launch a cloud solution expecting to provide neonatal intensive care unit doctors and parents access to a live video stream that they can watch anywhere from mobile devices such as smartphones and tablets.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
An examination of the heritability of atrial fibrillation (AF) among more than 4,000 participants in the Framingham Heart Study finds the occurrence of AF in first-degree relatives was associated with AF risk after adjustment for established AF risk factors and AF-related genetic variants, according to a study that will appear in the November 24 issue of JAMA.
› Verified 6 days ago
| Entity Name | Glps Staffing Solutions Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1750797015 PECOS PAC ID: 2365668043 Enrollment ID: O20140801002058 |
News Archive
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität aim to find answers to in a new research project in which they will be researching micrometastases that can form new tumours years after skin cancer, for example, has been treated successfully.
Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.
National Cheng Kung University, southern Taiwan, has collaborated with Quanta Computer to launch a cloud solution expecting to provide neonatal intensive care unit doctors and parents access to a live video stream that they can watch anywhere from mobile devices such as smartphones and tablets.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
An examination of the heritability of atrial fibrillation (AF) among more than 4,000 participants in the Framingham Heart Study finds the occurrence of AF in first-degree relatives was associated with AF risk after adjustment for established AF risk factors and AF-related genetic variants, according to a study that will appear in the November 24 issue of JAMA.
› Verified 6 days ago
| Entity Name | Asa Staffing Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114378981 PECOS PAC ID: 3971898644 Enrollment ID: O20160818002713 |
News Archive
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität aim to find answers to in a new research project in which they will be researching micrometastases that can form new tumours years after skin cancer, for example, has been treated successfully.
Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.
National Cheng Kung University, southern Taiwan, has collaborated with Quanta Computer to launch a cloud solution expecting to provide neonatal intensive care unit doctors and parents access to a live video stream that they can watch anywhere from mobile devices such as smartphones and tablets.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
An examination of the heritability of atrial fibrillation (AF) among more than 4,000 participants in the Framingham Heart Study finds the occurrence of AF in first-degree relatives was associated with AF risk after adjustment for established AF risk factors and AF-related genetic variants, according to a study that will appear in the November 24 issue of JAMA.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Matthew Thomas Blair, CRNA 324 Killarney Beach Rd, Bay City, MI 48706-1185 Ph: (423) 503-8874 | Matthew Thomas Blair, CRNA 1900 Columbus Ave, Bay City, MI 48708-6880 Ph: (989) 894-3000 |
News Archive
What is the likelihood of a patient developing cancer again after having a tumour removed? This is the question that experts in medicine and medical informatics at Friedrich-Alexander-Universität aim to find answers to in a new research project in which they will be researching micrometastases that can form new tumours years after skin cancer, for example, has been treated successfully.
Myriad Genetics, Inc. (Nasdaq: MYGN) announced today that it has launched a hereditary breast and ovarian cancer Public Awareness Campaign in five Midwest states, including Illinois, Indiana, Kentucky, Missouri and Ohio. The initiative is a comprehensive effort designed to reach women with a family history of breast and/or ovarian cancers and the healthcare providers that treat them.
National Cheng Kung University, southern Taiwan, has collaborated with Quanta Computer to launch a cloud solution expecting to provide neonatal intensive care unit doctors and parents access to a live video stream that they can watch anywhere from mobile devices such as smartphones and tablets.
A newly developed antifungal, isavuconazole, is as effective as an existing drug, voriconazole, against invasive mold disease in cancer patients with less adverse effects, according to phase 3 clinical data presented at the 54th Interscience Conference on Antimicrobial Agents and Chemotherapy, an infectious disease meeting of the American Society for Microbiology.
An examination of the heritability of atrial fibrillation (AF) among more than 4,000 participants in the Framingham Heart Study finds the occurrence of AF in first-degree relatives was associated with AF risk after adjustment for established AF risk factors and AF-related genetic variants, according to a study that will appear in the November 24 issue of JAMA.
› Verified 6 days ago
Scott Kowalewsky, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 989-894-3000 | |
Alison Spalding, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 989-894-3000 | |
Ashley Strohmer, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 214-242-8482 | |
Robert Allen Stockton, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 989-894-3000 Fax: 989-894-6138 | |
Laura Marie Acosta, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 989-894-3820 Fax: 989-891-0497 | |
Michael Lang, Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 1900 Columbus Ave, Bay City, MI 48708 Phone: 989-894-3000 |